van Laar JM - Search Results

1

Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells.

Morgan ME, Flierman R, van Duivenvoorde LM, Witteveen HJ, van Ewijk W, van Laar JM, de Vries RR, Toes RE. Morgan ME, et al. Among authors: van ewijk w, van duivenvoorde lm, van laar jm. Arthritis Rheum. 2005 Jul;52(7):2212-21. doi: 10.1002/art.21195. Arthritis Rheum. 2005. PMID: 15986351 Free article.

2

Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.

Teng YK, Levarht EW, Hashemi M, Bajema IM, Toes RE, Huizinga TW, van Laar JM. Teng YK, et al. Among authors: van laar jm. Arthritis Rheum. 2007 Dec;56(12):3909-18. doi: 10.1002/art.22967. Arthritis Rheum. 2007. PMID: 18050222 Free article.

3

Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis.

van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, van Laar JM. van Oosterhout M, et al. Among authors: van laar jm. Arthritis Rheum. 2008 Jan;58(1):53-60. doi: 10.1002/art.23148. Arthritis Rheum. 2008. PMID: 18163491 Free article.

4

High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review.

Verburg Ro, Toes RE, Fibbe WE, Breedveld FC, van Laar JM. Verburg Ro, et al. Among authors: van laar jm. Hum Immunol. 2002 Aug;63(8):627-37. doi: 10.1016/s0198-8859(02)00414-7. Hum Immunol. 2002. PMID: 12121670 Review.

5

Control of systemic B cell-mediated autoimmune disease by nonmyeloablative conditioning and major histocompatibility complex-mismatched allogeneic bone marrow transplantation.

Flierman R, Witteveen HJ, van der Voort EI, Huizinga TW, de Vries RR, Fibbe WE, Toes RE, van Laar JM. Flierman R, et al. Among authors: van der voort ei, van laar jm. Blood. 2005 Apr 1;105(7):2991-4. doi: 10.1182/blood-2004-09-3715. Epub 2004 Dec 16. Blood. 2005. PMID: 15604221 Free article.

6

Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.

Teng YK, Levarht EW, Toes RE, Huizinga TW, van Laar JM. Teng YK, et al. Among authors: van laar jm. Ann Rheum Dis. 2009 Jun;68(6):1011-6. doi: 10.1136/ard.2008.092791. Epub 2008 Jul 22. Ann Rheum Dis. 2009. PMID: 18647852

7

Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity.

Teng YK, Wheater G, Hogan VE, Stocks P, Levarht EW, Huizinga TW, Toes RE, van Laar JM. Teng YK, et al. Among authors: van laar jm. Arthritis Res Ther. 2012 Mar 12;14(2):R57. doi: 10.1186/ar3770. Arthritis Res Ther. 2012. PMID: 22409963 Free PMC article. Clinical Trial.

8

Therapeutic regulation of T cells in rheumatoid arthritis.

Breedveld FC, Struyk L, van Laar JM, Miltenburg AM, de Vries RR, van den Elsen PJ. Breedveld FC, et al. Among authors: van den elsen pj, van laar jm. Immunol Rev. 1995 Apr;144:5-16. doi: 10.1111/j.1600-065x.1995.tb00063.x. Immunol Rev. 1995. PMID: 7590820 Review.

9

Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis.

van Laar JM, Miltenburg AM, Verdonk MJ, Leow A, Elferink BG, Daha MR, Cohen IR, de Vries RR, Breedveld FC. van Laar JM, et al. J Autoimmun. 1993 Apr;6(2):159-67. doi: 10.1006/jaut.1993.1013. J Autoimmun. 1993. PMID: 8098938 Clinical Trial.

10

T cell vaccination in humans: the experience in rheumatoid arthritis.

van Laar JM, de Vries RR, Breedveld FC. van Laar JM, et al. Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S59-62. Clin Exp Rheumatol. 1993. PMID: 8324953

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

325 results

Search Page